Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Titration Phase	STARTED	JZP-110	174
Titration Phase	STARTED	Placebo	0
Titration Phase	COMPLETED	JZP-110	157
Titration Phase	COMPLETED	Placebo	0
Titration Phase	NOT COMPLETED	JZP-110	17
Titration Phase	NOT COMPLETED	Placebo	0
Stable-Dose Phase	STARTED	JZP-110	157
Stable-Dose Phase	STARTED	Placebo	0
Stable-Dose Phase	COMPLETED	JZP-110	124
Stable-Dose Phase	COMPLETED	Placebo	0
Stable-Dose Phase	NOT COMPLETED	JZP-110	33
Stable-Dose Phase	NOT COMPLETED	Placebo	0
Double-Blind Withdrawal Phase	STARTED	JZP-110	62
Double-Blind Withdrawal Phase	STARTED	Placebo	62
Double-Blind Withdrawal Phase	COMPLETED	JZP-110	60
Double-Blind Withdrawal Phase	COMPLETED	Placebo	62
Double-Blind Withdrawal Phase	NOT COMPLETED	JZP-110	2
Double-Blind Withdrawal Phase	NOT COMPLETED	Placebo	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02348619/flow